Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1); this is metadata about page revisions and does not alter study information or display.
    Difference
    0.1%
    Check dated 2026-02-17T03:23:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The History page now shows Revision: v3.4.1 added and Revision: v3.4.0 removed, a minor update to the version history display (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.1%
    Check dated 2026-02-09T22:59:59.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a banner stating that information may not be up to date due to a lapse in government funding. It notes that the NIH Clinical Center is open and provides links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.7%
    Check dated 2026-02-02T21:28:12.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, color-code explanations for changes (green/red highlights), a new revision label (v3.4.0), and removal of the 'No FEAR Act Data' item. These updates do not modify study data, eligibility, or results on the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-26T19:47:20.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    New revision v3.3.4 has been added to the study record history, updating the record from v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-19T13:57:25.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision v3.3.3 was added. HHS Vulnerability Disclosure and Revision v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-21T21:17:05.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.